More Alterity Therapeutics Ltd. news
Alterity Therapeutics Ltd.ASX: ATH

S&P DJ Indices Announces March Quarterly Rebalance

Nov 6, 2016 at 7:29 PM EST · Issued by Alterity Therapeutics Ltd.

Filed with ASX · Nov 6, 2016 at 7:29 PM EST · 10 pages · English

On 6ix: 6ix.com/news/sandp-dj-indices-announces-march-quarterly-rebalance-156

Alterity Therapeutics Ltd. on 6ix

Earlier from Alterity Therapeutics

  • Prana provides regulatory update for PBT2Nov 2, 2016
  • Prana announces $4.8 million R&D refundOct 30, 2016
  • New Reach2HD data presented at American Neurological Assoc.Oct 18, 2016
  • Prana announces $6.5 million R&D refundMay 9, 2016
  • FDA Orphan Drug Designation for PBT2 for Huntington DiseaseMar 30, 2016

Later from Alterity Therapeutics

  • S&P DJ Indices Announces March Quarterly ReviewNov 7, 2016
  • Business UpdateDec 23, 2016
  • Half Year AccountsFeb 24, 2017
  • PBT434 presented at 13th International AD/PD ConferenceMar 30, 2017
  • PBT434 Lowers Alpha-Synuclein and Prevents NeurodegenerationJul 3, 2017
All Alterity Therapeutics news releases↗

Follow Alterity Therapeutics into a list and get an email when it puts out news.

Follow Alterity Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer